Published by Josh White on 27th August 2024
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Tuesday that 'ACCRUFeR', or ferric maltol, had been approved by Health Canada as a prescription drug for the treatment of adults with iron deficiency anaemia (IDA).
URL: http://www.digitallook.com/dl/news/story/34515095/...